Cargando…

A parametric model to jointly characterize rate, duration, and severity of exacerbations in episodic diseases

BACKGROUND: The natural history of many chronic diseases is characterized by periods of increased disease activity, commonly referred to as flare-ups or exacerbations. Accurate characterization of the burden of these exacerbations is an important research objective. METHODS: The purpose of this work...

Descripción completa

Detalles Bibliográficos
Autores principales:	Safari, Abdollah, Petkau, John, FitzGerald, Mark J., Sadatsafavi, Mohsen
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2023
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837953/ https://www.ncbi.nlm.nih.gov/pubmed/36635713 http://dx.doi.org/10.1186/s12911-022-02080-5

Ejemplares similares

Heterogeneity's ruses: the neglected role of between-individual variability in longitudinal studies of COPD exacerbations
por: Sadatsafavi, Mohsen, et al.
Publicado: (2014)

Long-Term Natural History of Severe Asthma Exacerbations and Their Impact on the Disease Course
por: Lee, Tae Yoon, et al.
Publicado: (2022)

Direct costs of overdiagnosed asthma: a longitudinal, population-based cohort study in British Columbia, Canada
por: Ng, Bryan, et al.
Publicado: (2019)

The association between previous and future severe exacerbations of chronic obstructive pulmonary disease: Updating the literature using robust statistical methodology
por: Sadatsafavi, Mohsen, et al.
Publicado: (2018)

Cost-effectiveness of tiotropium versus omalizumab for uncontrolled allergic asthma in US
por: Zafari, Zafar, et al.
Publicado: (2018)

Cost-Effectiveness of Bronchial Thermoplasty, Omalizumab, and Standard Therapy for Moderate-to-Severe Allergic Asthma
por: Zafari, Zafar, et al.
Publicado: (2016)

The Projected Economic and Health Burden of Uncontrolled Asthma in the United States
por: Yaghoubi, Mohsen, et al.
Publicado: (2019)

Post-hospital syndrome in adults with asthma: a case-crossover study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2013)

The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model
por: Sadatsafavi, Mohsen, et al.
Publicado: (2016)

ACCEPT 2·0: Recalibrating and externally validating the Acute COPD exacerbation prediction tool (ACCEPT)
por: Safari, Abdollah, et al.
Publicado: (2022)

Should the number of acute exacerbations in the previous year be used to guide treatments in COPD?
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Trends in oral corticosteroids use in severe asthma: a 14-year population-based study
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Can we predict who will benefit most from biologics in severe asthma? A post-hoc analysis of two phase 3 trials
por: Chen, Wenjia, et al.
Publicado: (2023)

Heterogeneity in the respiratory symptoms of patients with mild-to-moderate COPD
por: Johnson, Kate M, et al.
Publicado: (2018)

Predictors of inappropriate and excessive use of reliever medications in asthma: a 16-year population-based study
por: Tavakoli, Hamid, et al.
Publicado: (2018)

Model-Based ROC Curve: Examining the Effect of Case Mix and Model Calibration on the ROC Plot
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Correction: Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2013)

Trends in Asthma-Related Direct Medical Costs from 2002 to 2007 in British Columbia, Canada: A Population Based-Cohort Study
por: Bedouch, Pierrick, et al.
Publicado: (2012)

Gender modifies the effect of body mass index on lung function decline in mild-to-moderate COPD patients: a pooled analysis
por: Chen, Wenjia, et al.
Publicado: (2021)

Risk factors of hospitalization and readmission of patients with COPD exacerbation – systematic review
por: Bahadori, Katayoon, et al.
Publicado: (2007)

Extent, trends, and determinants of controller/reliever balance in mild asthma: a 14-year population-based study
por: Khakban, Amir, et al.
Publicado: (2019)

Prescription duration and treatment episodes in oral glucocorticoid users: application of the parametric waiting time distribution
por: Laugesen, Kristina, et al.
Publicado: (2017)

Complementary and alternative asthma treatments and their association with asthma control: a population-based study
por: Chen, Wenjia, et al.
Publicado: (2013)

Concurrent physician-diagnosed asthma and chronic obstructive pulmonary disease: A population study of prevalence, incidence and mortality
por: Kendzerska, Tetyana, et al.
Publicado: (2017)

Trends in prescriptions and costs of inhaled medications in chronic obstructive pulmonary disease: a 19-year population-based study from Canada
por: Tavakoli, Hamid, et al.
Publicado: (2019)

The economics of precision health: preventing air pollution-induced exacerbation in asthma
por: Mohammadi, Tima, et al.
Publicado: (2021)

Future Impact of Various Interventions on the Burden of COPD in Canada: A Dynamic Population Model
por: Najafzadeh, Mehdi, et al.
Publicado: (2012)

The cost-effectiveness of as-needed budesonide-formoterol versus low-dose inhaled corticosteroid maintenance therapy in patients with mild asthma in Canada
por: Sadatsafavi, Mohsen, et al.
Publicado: (2021)

Benefit–harm analysis of azithromycin for the prevention of acute exacerbations of chronic obstructive pulmonary disease
por: Ahmadian, Safa, et al.
Publicado: (2022)

Asthma exacerbations and worsenings in patients aged 1–75 years with add-on tiotropium treatment
por: Mark FitzGerald, J., et al.
Publicado: (2020)

The impact of comorbidities on productivity loss in asthma patients
por: Ehteshami-Afshar, Solmaz, et al.
Publicado: (2016)

Effect of erdosteine on the rate and duration of COPD exacerbations: the RESTORE study
por: Dal Negro, Roberto W., et al.
Publicado: (2017)

Statin use and lung cancer risk in chronic obstructive pulmonary disease patients: a population-based cohort study
por: Raymakers, AJN, et al.
Publicado: (2020)

The burden of exacerbations in mild asthma: a systematic review
por: FitzGerald, J. Mark, et al.
Publicado: (2020)

Early biomarkers of joint damage in rheumatoid and psoriatic arthritis
por: Mc Ardle, Angela, et al.
Publicado: (2015)

Sensory Processing Disorders are Associated with Duration of Current Episode and Severity of Side Effects
por: Serafini, Gianluca, et al.
Publicado: (2017)

The effect of weather variables on the severity, duration, and frequency of headache attacks in the cases of episodic migraine and episodic tension-type headache
por: AKGÜN, Nergis, et al.
Publicado: (2021)

Individualised risk prediction model for exacerbations in patients with severe asthma: protocol for a multicentre real-world risk modelling study
por: Lee, Tae Yoon, et al.
Publicado: (2023)

The effect of COPD severity and study duration on exacerbation outcome in randomized controlled trials
por: Eriksson, Göran, et al.
Publicado: (2017)

Empowering pharmacists in asthma management through interactive SMS (EmPhAsIS): study protocol for a randomized controlled trial
por: De Vera, Mary A, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_mei1dte1rud4bcpd8qmcts75uj